.png)
RDC 1,014/2026: the medical cannabis regulatory sandbox
RDC 1.014/2026
Anvisa
Regulatory sandbox: experimental environment for cultivating and preparing medical cannabis.

RDC 1,014/2026: cannabis regulatory sandbox | Brazcann
What it is and regulatory context
RDC 1,014/2026 introduces into the cannabis sector a modern regulatory instrument: the regulatory sandbox. It is an experimental, controlled environment, with a defined term and scope, in which models not yet fully foreseen by traditional regulation can be tested under Anvisa's supervision. It is a way for the agency to learn from practice before consolidating definitive rules for the sector.
What the rule establishes
The resolution sets the conditions for participation in the sandbox — aimed, among other topics, at the cultivation and preparations of medical cannabis —, including criteria for selection, monitoring and evaluation of projects. Participants operate under specific regulatory flexibilities, in exchange for rigorous oversight, generating data that will guide the improvement of the rules in the future.
Who it applies to and impacts
It applies to organizations — companies, associations and institutions — interested in testing innovative models of production, preparation or dispensing of medical cannabis. For patient associations and smaller initiatives, in particular, the sandbox can represent a regulated entry door, allowing them to operate with legal certainty while contributing to building the definitive framework.
Deadlines, validity and access
RDC 1,014/2026 is already in force, awaiting the call (the summoning of participants) by Anvisa. Interested organizations should prepare their projects for when selection opens. Brazcann follows the topic and supports the structuring of proposals. The official text is available on datalegis/Anvisa. Informative content, not a legal opinion.
Why this matters
The great advantage of the sandbox is to allow innovation with backing: instead of operating informally or waiting indefinitely for a perfect rule, the organization tests its model within a safe, supervised perimeter, generating data that help Anvisa itself build the definitive rules. For patient associations in particular, this can mean the regularization of practices that today live in a gray zone, bringing legal certainty to initiatives of great social impact. Selection, however, tends to be competitive and requires well-founded proposals. Brazcann follows the call and structures solid applications for the regulatory sandbox.
Frequently asked questions
What is the regulatory sandbox?
An experimental, controlled environment, with a defined term, to test cannabis models under Anvisa's supervision.
Is it already in force?
Yes, it is in force, awaiting the call (summoning) of participants by Anvisa.

